Filing Details
- Accession Number:
- 0001246360-14-001881
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-03-21 15:14:09
- Reporting Period:
- 2014-03-20
- Filing Date:
- 2014-03-21
- Accepted Time:
- 2014-03-21 15:14:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 64670 | Medtronic Inc | MDT | Electromedical & Electrotherapeutic Apparatus (3845) | 410793183 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1438538 | M Catherine Szyman | 710 Medtronic Pkwy Ms Lc300 Minneapolis MN 55432 | Srvp & Pres Diabetes | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-03-20 | 14,335 | $34.88 | 35,877 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-03-20 | 644 | $38.81 | 36,521 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-03-20 | 14,979 | $59.57 | 21,542 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2014-03-20 | 14,335 | $0.00 | 14,335 | $34.88 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2014-03-20 | 644 | $0.00 | 644 | $38.81 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 14,335 | 2012-08-01 | 2021-08-01 | No | 4 | M | Direct |
| 25,123 | 2013-07-30 | 2022-07-30 | No | 4 | M | Direct |
Footnotes
- These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
- This balance increased by 325.355 shares due to exempt transactions such as dividend reinvestment and employee stock purchase plan.
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.23 to $59.73, inclusive. The reporting person undertakes to provide to Medtronic, Inc., any security holder of Medtronic, Inc., or the staff of the Secruities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this Form 4.
Billionaire Hedge Funds
